Salvianolic Acid A Protects Neonatal Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Injury by Preserving Mitochondrial Function and Activating Akt/GSK-3β Signals
- 89 Downloads
To investigate the effects of salvianolic acid A (SAA) on cardiomyocyte apoptosis and mitochondrial dysfunction in response to hypoxia/reoxygenation (H/R) injury and to determine whether the Akt signaling pathway might play a role.
An in vitro model of H/R injury was used to study outcomes on primary cultured neonatal rat cardiomyocytes. The cardiomyocytes were treated with 12.5, 25, 50 μg/mL SAA at the beginning of hypoxia and reoxygenation, respectively. Adenosine triphospate (ATP) and reactive oxygen species (ROS) levels were assayed. Cell apoptosis was evaluated by flow cytometry and the expression of cleaved-caspase 3, Bax and Bcl-2 were detected by Western blotting. The effects of SAA on mitochondrial dysfunction were examined by determining the mitochondrial membrane potential (△Ψm) and mitochondrial permeability transition pore (mPTP), followed by the phosphorylation of Akt (p-Akt) and GSK-3β (p-GSK-3β), which were measured by Western blotting.
SAA significantly preserved ATP levels and reduced ROS production. Importantly, SAA markedly reduced the number of apoptotic cells and decreased cleaved-caspase 3 expression levels, while also reducing the ratio of Bax/Bcl-2. Furthermore, SAA prevented the loss of △Ψm and inhibited the activation of mPTP. Western blotting experiments further revealed that SAA significantly increased the expression of p-Akt and p-GSK-3β, and the increase in p-GSK-3β expression was attenuated after inhibition of the Akt signaling pathway with LY294002.
SAA has a protective effect on cardiomyocyte H/R injury; the underlying mechanism may be related to the preservation of mitochondrial function and the activation of the Akt/GSK-3β signaling pathway.
Keywordssalvianolic acid A cardiomyocyte hypoxia/reoxygenation injury mitochondria Akt/GSK-3β
Unable to display preview. Download preview PDF.
- 2.Zhang L, Zhang WK, Zhao Y, Yang X, Fang L, Wang S, et al. Research progress of salvianolic acid A. China J Chin Mater Med 2011;36:2603–2609.Google Scholar
- 3.Fan HY, Yang L, Fu FH, Xu H, Meng QG, Zhu HB, et al. Cardioprotective effects of salvianolic acid A on myocardial ischemia-reperfusion injury in vivo and in vitro. Evid Based Complement Alternat Med 2012;2012:508938.Google Scholar
- 4.Yang XY, Qiang GF, Zhang L, Du GH. Myocardial protection from ischemia-reperfusion injury by salvianolic acid A in rats. Chin Pharmacol Bull 2011;27:1072–1076.Google Scholar
- 5.Lin L, Liu JX, Zhang Y, Li XZ, Duan CL, Lin CR, et al. Simultaneous determination of salvianolic acid A, salvianolic acid B, rosmarinic acid and lithospermic acid in dog plasma by LC-MS/MS: application to pharmacokinetic study of Salvia Miltiorrhiza extraction. World Sci Technol Modern 2012;14:1567–1571.Google Scholar
- 6.Lin L, Liu JX, Zhang Y, Li XZ, Lin CR, An JB. A PK/PD processing study on Chinese formulation of Shuang-Shen-Tong-Guan Prescription. World Sci Technol Modern 2012;14:1583–1589.Google Scholar
- 7.Li P, Ren JG, Duan CL, Lin CR, Liu JX. The effects of three components of Salviae miltiorrhizae radix on anoxia and peroxidation injuries in neonatal cardiomyocytes. Pharmacol Clin Chin Mater Med 2009;25:29–31.Google Scholar
- 9.Zheng J, Zhang XL, Zhou JL, Dang YM, Zhang JP, Liu CY, et al. Effects of microtubule disassembly on hypoxic injury of cultured cardiomyocytes. Acta Acad Med Milit Tertiae (Chin) 2006;28:617–620.Google Scholar
- 10.Parhamifar L, Andersen H, Moghimi SM. Lactate dehydrogenase assay for assessment of polycation cytotoxicity. Method Mol Biol 2013;948:13–22.Google Scholar